Tomoaki Tanaka,
Associate Professor, Department of Urology
Osaka City University Graduate School of Medicine, Japan
Kurt S Zaenker, Professor, Department of Immunology/Biochemistry/Oncology Witten-Herdecke University, Germany
Xiangchun Wang,
Analytical Scientist, NIAID/NIH, USA
H-Factor: 11
Index Copernicus Value: 103.52
Research Gate Journal Impact- 0.45*
Journal of Cancer Sciences and Therapy is a peer reviewed journal serving the International Scientific Community. This journal offers an open access platform to the authors to publish their research outcome and thus help in promoting Cancer and Oncology research.
Journal of Cancer Science and Therapy is an Open Access publishing that aims to focus on the most complete and reliable source of information on discoveries and current developments as original article, review articles, case reports, short communications, etc. related to Cancer research and therapy and provides free online access to the researchers worldwide.
This top best scholarly journal is using Editorial Tracking System for online manuscript submission, review and tracking. Editorial board members of the JCST or outside experts review manuscripts; at least two independent reviewer’s approval followed by the editor is required for the acceptance of any citable manuscript.
Submit manuscript online at https://www.scholarscentral.org/submissions/cancer-science-therapy.html or send as an e-mail attachment to the Editorial Office at editor@hilarispublisher.com
Rapid Publication Service
Hilaris Publishing is offering wide range of opportunities, options and services for the prospective authors to publish their scholarly contributions.
The journal caters to the demands of the fast publication without compromising on the editorial quality including manuscript peer-review. This flexibility is being provided to ensure earliest author credibility to their respective contributions and this will also ensure timely dissemination of research outcomes for efficient integration, effective translation and reduced redundancy.
Authors have the option to choose between the standard open access publication service which takes its own course of time for complete publication process or can opt for rapid publication service wherein the article is published at the earliest date (Includes multiple subject experts commissioning for securing earliest peer-review comments). The authors can avail this flexibility based on the personal preference, funding agency guidelines or Institutional or organizational requirements.
Regardless of the option, all manuscripts undergo thorough peer-review process, editorial assessment and production process.
Fast Editorial Execution and Review Process (FEE-Review Process)
Authors who are willing to publish their articles under this mode can make a pre-payment of $99 towards express peer-review and editorial decision. First editorial decision in 3 days and final decision with review comments in 5 days from the date of submission. Galley proof generation will be done in next 2 days from acceptance or maximum 5 days (For manuscripts notified for revision by external reviewer).
Manuscripts accepted for publication will be charged regular APC.
Authors retain the copyright of their publication and the final version of the article will be published in both HTML and PDF formats as well as XML formats for transmitting to indexing databases. The editorial team of the Journal will ensure adherence to scientific publication guidelines.
Articles published in Cancer Science & Therapy have been cited by esteemed scholars and scientists all around the world. Cancer Science & Therapy has got h-index 25 , which means every article in Cancer Science & Therapy has got 25 average citations.
Marco Imbalzano*
2021 Conference Announcement
Marco Imbalzano*
2021 Conference Announcement
Marco Imbalzano*
2021 Conference Announcement
Marco Imbalzano*
2021 Conference Announcement
Cancer Science & Therapy received 3771 citations as per Google Scholar report
